| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |